The most recurrent WD40 domain TRAF7 mutants found in meningioma displayed a markedly reduced ability to bind either CDC42 or HRas, whereas mutations in the RING catalytic domain of TRAF7 (such as TRAF7-R153S) had no effect on CDC42 or HRas binding. Here, HRAS is linked to meningioma.